11-47677371-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_024783.4(AGBL2):c.2047C>T(p.Leu683Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000059 in 1,609,244 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_024783.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AGBL2 | NM_024783.4 | c.2047C>T | p.Leu683Phe | missense_variant | Exon 14 of 19 | ENST00000525123.6 | NP_079059.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AGBL2 | ENST00000525123.6 | c.2047C>T | p.Leu683Phe | missense_variant | Exon 14 of 19 | 1 | NM_024783.4 | ENSP00000435582.1 | ||
AGBL2 | ENST00000528244.5 | c.1933C>T | p.Leu645Phe | missense_variant | Exon 13 of 16 | 2 | ENSP00000436630.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152138Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000805 AC: 2AN: 248358Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 134260
GnomAD4 exome AF: 0.0000631 AC: 92AN: 1457106Hom.: 0 Cov.: 30 AF XY: 0.0000690 AC XY: 50AN XY: 724862
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152138Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74314
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.2047C>T (p.L683F) alteration is located in exon 14 (coding exon 13) of the AGBL2 gene. This alteration results from a C to T substitution at nucleotide position 2047, causing the leucine (L) at amino acid position 683 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at